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Introduction 
  Indoleamine 2,3-dioxygenase (h-IDO) is an enzyme 
catalyzing the initial and rate-limiting step in the 
catabolism of tryptophan along the kynurenine 
pathway (Figures 1 & 2). This enzyme is located in 
brain and has been detected in high concentration in 
human tumor cells. Furthermore this enzyme could 
be responsible for the suppression of immune 
responses by blocking locally T-lymphocyte 
proliferation.[1,2]  
Figure 1 | The two first steps in the catabolism of L-tryptophan along 
the kynurenine pathway 
Results 
 The automated radiosynthesis of 18FETrp 5 needs 
the prior synthesis of a precursor owing a tosyl 
moiety which allows the easy introduction of the 
radioactive [18F]fluoride (t½ = 109,7min) by a 
classical method with potassium carbonate and 
kryptopfix[4,5]. 
 
1. Precursor Synthesis 
 
  The tosylate precursor 3 was synthesized in three 
steps starting from L-tryptophan 1 (Scheme 1). 
















  This amino acid was firstly protected with two 
acidic leaving groups, with a global yield of 38% for 
two steps. 
  Then the intermediate 2 was alkylated with 
ethylene glycol ditosylate, to afford the tosylate 
precursor 3 (yield: 49%). 
 
 
2. Automated Radiosynthesis on FASTlabTM  
 
  To optimize radioprotection, the whole 
radiosynthesis of 1-(2-[18F]fluoroethyl)-tryptophan 
was carried out on a GE Healthcare FASTlabTM 
automated system (Figure 2). 
 
Conclusion 
  Herein, an automated synthesis of 1-(2-[18F]fluoroethyl)-tryptophan, with good radiochemical yields, has been developed. In vitro studies with cold reference 19FETrp 
show that [19F]5 is a good and specific substrate of h-IDO. Moreover, some studies with this new radiochemical compound, still under progress, could confirm that 
18FETrp ([18F]5) is a molecule of choice to bring out the presence of h-IDO, an enzyme which is located in brain and tumor cells. 
  The tosylate precursor 3 was labeled[4,5] (Scheme 
2) under different conditions (Table 1). The best 
radiochemical decay-corrected yield (RCY) (57%) 
was obtained when the labeling was carried out in 
DMF, for 5 minutes at 140ºC (n = 3).  
 
   
[18F]5 [19F]5 
Figure 3 | HPLC chromatogram of purified and 
formulated nca 18FETrp (in red) and cold reference 
19FETrp (in blue) Figure 2 | GE Healthcare FASTlabTM synthesizer 
  Therefore, a radiotracer based on tryptophan 
structure seems to be well adapted to bring out the 
presence of h-IDO, and thus, of tumors. 
  Herein, an automated radiosynthesis of the 1-(2-
[18F]fluoroethyl)-tryptophan (18FETrp), a radiotracer 
previously described,[3] is reported. 
Figure 2 | Structure of h-IDO 
Scheme 1 | Synthesis of 1-(2-tosyloxyethyl)-
tryptophan 3 (precursor) 
Scheme 2 | Radiochemical synthesis of  
1-(2-[18F]fluoroethyl)-tryptophan 5 (18FETrp)  
  The intermediate 4 was purified on a tC18 solid 
phase extraction cartridge (Sep-Pak®) and 
hydrolyzed at 90ºC for 10 minutes, to give the 
18FETrp 5 (Scheme 2).  
  Finally the labeled compound 5 was purified on 
semi-preparative HPLC and formulated. 
Table 1 | Influence of solvent and temperature on 
the radiochemical decay-corrected yield (RCY) of 3 
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Solvent Temperature Time RCY 
ACN 
90 ºC 10 min 28% 
120 ºC 3 min 25% 
DMF 
140 ºC 3 min 51% 
140 ºC 5 min 57% 
  The fully automated process takes around 40 
minutes and the 18FETrp 5 was obtained, after 
purification on semi-preparative HPLC, with global 
radiochemical decay-corrected yield of 30% (n = 5). 
The radiochemical purity was >98%.  
 
3. Enzymatic Tests  
 
  In vitro enzymatic tests with recombinant h-IDO[6] 
were carried out with cold reference 19FETrp, in 
presence of methylene blue [100µM], ascorbic acid 
[200mM] and sodium phosphate buffer [50mM, pH 
6.5] at 37ºC. Figure 4 shows the decrease of the 
fluorescence signal of 19FETrp, studied by HPLC, 
according to the time of incubation. This decrease is 
due to the opening of the indole ring of the 
substrate. For a concentration of substrates smaller 
than Km, the kcat/Km – values (Table 2) were 
determined from curves (Figure 4). Furthermore, 
[19F]5 is not a substrate of recombinant h-TDO[7], an 
enzyme expressed in liver (Table 2). Thus 19FETrp is 
a specific substrate of h-IDO. 
Table 2 | In vitro enzymatic tests realized with [19F]5 
and some other substrates known for h-IDO and 
h-TDO (37ºC, pH 6.5) 
Figure 4 | HPLC chromatogram superposition 
showing the decrease of the fluorescence signal of 
19FETrp in function of incubation time 
Tested 
Substrates 
Percentage of substrate consumed 












L-Trp 1 > 97 100 1700±400 67 100 
N-Me-Trp 100 100 38±17 0 3 
5-HO-Trp 100 100 21±4 0 14 
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